SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs informs about closure of trading window

03 Oct 2023 Evaluate

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Kabra Drugs has informed that the trading window shall remain closed from October 1, 2023 till 48 hours after announcement of the Unaudited Financial Results for the Quarter Ended 30th September, 2023. The date of Board Meeting will be informed in due course.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

27.01 -1.28 (-4.52%)
13-Apr-2026 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.20
Dr. Reddys Lab 1224.05
Cipla 1213.90
Zydus Lifesciences 925.80
Lupin 2321.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×